EZH2 expression is reportedly increased in murine prostate cancer (PCa) [4] and lymphoma cell lines [5] as well as in human primary tumor cells, such as breast cancer [6], melanoma [7], and pancreatic cancer [8]. Here, EZH2 is linked to melanoma.